Driehaus Capital Management’s Braveheart Bio BRVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.57M Buy
+77,500
New +$2.04M 0.01% 364

Other funds holding BRVE

Driehaus Capital Management's BRVE Position: Q3 2026 in Review

Driehaus Capital Management opened a new position in Braveheart Bio (BRVE) in Q3 2026: 77,500 shares worth $1.57M. The stake represents 0.01% of the portfolio and ranks #364 among its holdings.

64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.

  • Driehaus Capital Management held 77,500 shares of Braveheart Bio worth $1.57M as of Q3 2026.
  • Braveheart Bio was a new Driehaus Capital Management position in Q3 2026.
  • Braveheart Bio made up 0.01% of Driehaus Capital Management's portfolio in Q3 2026, its #364 holding.
  • 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.

Based on Driehaus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.